• by Gary Pisano
  • Narrated by Todd Mundt
  • 0 hrs and 49 mins
  • Periodical

Publisher's Summary

In 1976, Genentech, the first biotechnology company, was founded by a young venture capitalist and a university professor to exploit recombinant DNA technology. Thirty years and more than $300 billion in investments later, only a handful of biotech firms have matched Genentech's success or even shown a profit. No avalanche of new drugs has hit the market, and the long-awaited breakthrough in R&D productivity has yet to materialize. This disappointing performance raises a question: Can organizations motivated by the need to make profits and please shareholders successfully conduct basic scientific research as a core activity? From the October 2006 issue of Harvard Business Review.


See More Like This

Customer Reviews

Most Helpful


This seemed to a non expert expert a thorough review of biotech's industry present state.
Read full review

- Ariel

Book Details

  • Release Date: 11-10-2006
  • Publisher: Harvard Business School Publishing